ESF Research Conferences

ESF-EMBO Symposium

Antiviral RNAi: From Molecular Biology Towards Applications

Programme

Monday 11th June
17:00 - 19:00
Registrations at ESF desk
19:00
Welcome Drink
20:00
Dinner

Tuesday 12th June

08.45-09.00

Conference Opening

Session I : RNAi and viral infections in mammals

Chair: B. Berkhout, Academic Medical Center, University of Amsterdam, NL

09.00-09.30

M. Kay, Stanford University, US

RNAi approaches for HCV Infection- Is the anti-genome a viable target?

09.30-10.00

A. Russo, Second University of Naples, IT

Role of cellular microRNAs in hepatitis B virus infection

10.00-10.30

Y.P. Liu, University of Amsterdam, NL

Dicer-independent processing of shRNAs

10.30-11.00Coffee Break
11.00-11.30

K.-T. Jeang, The National Institutes of Health, US

Long- and short- non-coding RNAs and other factors that modulate mammalian viral replication

11.30-12.00

Y. Bennasser, Institute of Human Genetics, FR

HIV uses cellular miRNAs to better replicate

12.00-12.30

S. Pfeffer, CNRS, FR

Roles and regulation of microRNAs in viral infections

12.30-12.50

W. Kamel, Uppsala University, SE

The adenovirus VA RNAI derived miRNAs are not required for lytic virus growth

12.50-15.00Lunch

Session 2 RNAi and viral infections beyond mammals

Chair J.A. Garcia, Centro Nacional de Biotecnologia, Campus de la Universidad Autonoma, ES

15.00-15.30

M.-A. Felix, CNRS-University of Paris-Diderot, FR

Viral infections of Caenorhabditis nematodes

15.30-16.00

R. van Rij, Radboud University, NL

Defense and counter-defense in the RNAi-based antiviral immune system of insects

16.00-16.20

J. Van Mierlo, Radboud University Nijmegen, NL

Convergent evolution of Argonaute-2 Slicer antagonism in two insect RNA viruses

16.20-16.50Coffee break

16.50-17.10

E. Schnettler, MRC- University of Glasgow, UK

Characterization of the antiviral RNA silencing response in an Ixodes scapularis tick cell line 

17.10-17.30

E. Girardi, Université de Strasbourg, FR

Identification of viral small RNAs from an arthopod-borne RNA virus in mammalian cells

17.30-17.50

W. Chen, Chang Gung University, TW

Additive protection by antioxidant and apoptosis-inhibiting effects on mosquito cells with dengue 2 virus infection

17.50-18.20

T. Dalmay, University of East Anglia, UK

Reducing sequencing bias of small RNAs

18.30-20.30Dinner
20.30-22.00Poster Session
Wednesday 13th June
Session 3 Counter defence and counter-counter defence in viral infections
Chair:  R. van Rij, Radboud University, NL 
08.45-09.15

Th. Hohn, University of Basel, CH

Plant DNA viruses, silencing and silencing suppression

09.15-09.45

J.A. Garcia, Centro Nacional de Biotecnologia CSIC, ES

Host specific functions of potyvirid HC and P1 proteins in RNA silencing suppression... and something else

09.45-10.05

E. Truve, Tallinn University of Technology, EE

Human RNase L inhibitor is a suppressor of RNA silencing

10.05-10.35Coffe break and group photo
10.35-11.05

J. Burgyan, Ministry of Rural Development, HU

Small RNAs and their targets in virus infected plants

11.05-11.25

V. Pantaleo, Istituto di Virologia Vegetale del CNR, IT

Genome-wide identification of host transcripts targeted by viral siRNAs in V. vinifera

11.25-11.55

S. Elena, Instituto de Biología Molecular y Celular de Plantas (CSIC-UPV), ES

Population Dynamics of Virus Escape Mutants in RNAi-mediated Resistant Plants

11.55-12.15

A. Voloudakis, Agricultural University of Athens, GR

COST FA0806-Plant virus control employing RNA-based vaccines: A novel non-transgenic strategy

12.30-14.30Lunch
14.30-16.30COST meeting
16-30-17.00Coffee break
Session 4 : Interplay between RNAi and other antiviral defence mechanisms
Chair:  J. Kurreck, Institut für Biotechnologie, Technische Universität Berlin, DE 
17.00-17.30

J-L. Imler, Université de Strasbourg / CNRS, FR

Antiviral silencing in insects

17.30-17.50

C. Donald, University of Glasgow, UK

The role of mosquito innate immune response in controlling arbovirus infection and replication

17.50-18.20

P. Fortes, CIMA/UNAV, ES

Increased inhibition of gene expression by combining RNAi and U1i

18.20-18.50

C. Coch, Universitätsklinikum Bonn, DE

Rational design of synthetic ligands for the innate immune receptor RIG-I as novel antiviral treatment

19.00-20.30Dinner
20.30-22.00Poster Session

Thursday 14th June

09.00-09.30

A. Gatignol, McGill University, CA

RNA interference, RNA editing and PKR pathways in viral infections

09.30-10.00

A. Karlas, Max-Planck-Institute for Infection Biology, DE

Global identification of host cell factors essential for influenza A virus replication

10.00-10.20

S. Ponia, National Institute of Immunology, IN

Modular Organization of Host - Pathogen interaction in HIV-1 mediated RNAi Perturbation

10.20-10.50Coffee break

Session 5 Towards therapeutics

Chair K.-T. Jeang, The National Institutes of Health, US

10.50-11.20

R. Adamiak, Polish Academy of Sciences, PL

Fully automated 3D RNA structure prediction of the lentiviral leaders

11.20-11.40

A. Kurzynska, Institute of Bioorganic Chemistry, PL

Regulation of microRNA biogenesis by RNA oligonucleotides

11.40-12.10

T. KochSantaris Pharma A/S, DK

Locked Nucleic Acid: MicroRNA as target for treatment of hepatitis C virus infection

12.30-14.30Lunch
14.30-15.00

D. Grimm, University of Heidelberg, DE

Tailoring of Adeno-associated viruses as anti-viral RNAi reagents

15.00-15.30

J. Kurreck, Technische Universität Berlin, DE

Combinatorial RNAi approaches against coxsackievirus B3

15.30-16.00

B. Berkhout, University of Amsterdam, NL

RNAi based gene therapy for HIV-AIDS

16.00-16.30

J. De Vicenzo, University of Tennessee, US

RNA interference strategies for human respiratory syncytial virus:  Establishing proof of principle in man and progress of ongoing clinical trials

16.30-17.00Coffee break
17.00-18.30Poster Session and Poster Prizes
18.30-19.30Future perspectives and general discussion
20.00Conference dinner
Friday 15 June
08:00Breakfast and Departure